Table 2 Tiling array sequencing results of 6 clinical samples
From: A full genome tiling array enhanced the inspection and quarantine of SARS-CoV-2
Group | Samples | CT value | Coverage | Detected mutations |
|---|---|---|---|---|
SP | CS-1 | 25.0 | 99.76% | A23403G, C241T, C884G, G1505A, C3037T, A5852G, G8131T, A8621G, A8833T, T9106C, A9266G, A9656G, A10840G, C13329T, G13690A, C14408T, G18255T, A20755T, G21641A, A21706G, A29735G |
1.2–105 | 22.0 | 99.92% | A23403G, C241T, C2455T, C3037T, C6629T, C14408T, C15273T, C17502T, C18877T, C21304T, C21731T, A21917G, G25563T, C25916T, C26735T, T27384C, C28869T, C29095T | |
9.8–16 | 20.0 | 99.96% | A23403G, C241T, C3037T, C8208T, C14408T, C23987T, C25416T | |
WP | 9.16–21 | 30.0 | 99.68% | A23403G, C241T, G2720A, C3037T, C6762T, G7042T, C9226T, C14408T, C16017T, C16111T, T17454A, G19072T, C19216T, A20755T, C21575T, A21706G, C23557T, A23933C, G25429T, G28077T, G28842T, A29301G |
9.17–8 | 31.0 | 99.93% | A23403G, C241T, C3037T, C6099A, C6762T, G7042T, C7318A, C9226T, C12854T, C14408T, C14913T, C16017T, C16111T, G19072T, G19997A, C21575T, C23557T, G25429T, G28077T, G28842T | |
9.17–11 | 30.0 | 99.92% | A23403G, C241T, C3037T, C6762T, G7042T, C9226T, C14408T, C16017T, C16111T, G19072T, C21575T, C23557T, G25429T, G28077T, G28842T |